Roxicodone and Osteoarthritis - a phase IV clinical study of FDA data

Summary:

Osteoarthritis is reported as a side effect among people who take Roxicodone (oxycodone hydrochloride), especially for people who are male, 60+ old, also take Celebrex, and have Osteoporosis.

The phase IV clinical study analyzes which people have Osteoarthritis when taking Roxicodone. It is created by eHealthMe based on reports of 19,861 people who have side effects when taking Roxicodone from the FDA, and is updated regularly.

What is Roxicodone?

Roxicodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 20,099 Roxicodone users. Check the latest studies of Roxicodone.

What is Osteoarthritis?

Osteoarthritis (a joint disease caused by cartilage loss in a joint) is found to be associated with 1,878 drugs and 2,647 conditions by eHealthMe. Check the latest studies of Osteoarthritis.

On Jul, 31, 2026

19,861 people reported to have side effects when taking Roxicodone.
Among them, 84 people (0.42%) have Osteoarthritis.

Among these 84 people:

What is the gender of people who have Osteoarthritis when taking Roxicodone? *

female: 34.15 %
male: 65.85 %

What is the age of people who have Osteoarthritis when taking Roxicodone? *

What are other drugs people take besides Roxicodone? *

What are other side effects people have besides Osteoarthritis? *

Bone Disorder: 40 people, 47.62%
Osteonecrosis Of Jaw (death of bone of jaw): 39 people, 46.43%
Weakness: 38 people, 45.24%
Pain In Jaw: 38 people, 45.24%
Intervertebral Disc Protrusion (spinal disc protrusion): 36 people, 42.86%
Pain In Extremity: 36 people, 42.86%
Stress And Anxiety: 35 people, 41.67%
Injury: 35 people, 41.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 33 people, 39.29%
Joint Pain: 30 people, 35.71%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 30 people, 35.71%
Prostate Cancer Metastatic: 10 people, 11.90%
Multiple Myeloma (cancer of the plasma cells): 9 people, 10.71%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 4.76%
High Blood Pressure: 3 people, 3.57%
Stress And Anxiety: 3 people, 3.57%
Sleep Disorder: 3 people, 3.57%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Roxicodone and have Osteoarthritis?

- Check whether Osteoarthritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Roxicodone:

Roxicodone (20,099 reports)

Osteoarthritis treatments and more:

Osteoarthritis (95,654 reports)

Browse all side effects of Roxicodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteoarthritis:

Osteoarthritis (1,878 drugs)

Browse all the conditions that are associated with Osteoarthritis:

Osteoarthritis (2,647 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Roxicodone) and Roxicodone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.